- Verified Reactivity
- Mouse, Human
- Reported Reactivity
- Cat
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Abelson murine leukemia virus-induced pre-B tumor cells
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.
- Application Notes
Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.
- Additional Product Notes
BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
- George A, et al. 1994. J. Immunol. 152:1014. (Activ)
- Asensi V, et al. 1989. Immunology 68:204. (Activ)
- Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
- Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
- Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
- Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
- Chang C L-T, et al. 2007. J. Immunol. 178:6984.
- Fazilleau N, et al. 2007. Nature Immunol. 8:753.
- Lang GL, et al. 2008. Blood 111:2158. PubMed
- Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
- del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
- Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
- Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
- Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
- Product Citations
-
- Sasaki I, et al. 2012. Blood. 120:4733. PubMed
- Lang J, et al. 2020. Nat Commun. 11:1338. PubMed
- Zenke S, et al. 2022. Nat Commun. 13:6459. PubMed
- Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
- Macal M, et al. 2016. J Immunol. 196: 1900 - 1909. PubMed
- Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
- Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
- Page N, et al. 2018. Immunity. 48:937. PubMed
- Degn SE et al. 2017. Cell. 170(5):913-926 . PubMed
- Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
- Kong S, et al. 2015. J Immunol. 195: 3685 - 3693. PubMed
- Kobayashi T, et al. 2019. Cell. 176:982. PubMed
- Feng J, et al. 2021. iScience. 24:103004. PubMed
- Pack AD, et al. 2021. Cell Reports. 36(8):109586. PubMed
- Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
- Lutzmann M, et al. 2019. Cell Rep. 28:2851. PubMed
- Yasuoka T, et al. 2016. PLoS One. 11: 0157395. PubMed
- Pan H, et al. 2020. Mol Psychiatry. . PubMed
- Wang X, et al. 2020. Signal Transduct Target Ther. 5:35. PubMed
- Elsner RA, et al. 2020. Cell Reports. 29(9):2796-2809.e5.. PubMed
- Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
- Kong S, et al. 2014. J Immunol. 193:5515. PubMed
- Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
- Sugita J, et al. 2021. Nat Commun. 12:1910. PubMed
- Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
- Chen L, et al. 2020. J Exp Med. 217:00:00. PubMed
- Stivala S, et al. 2019. J Clin Invest. 130:1596. PubMed
- Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
- Rivadeneira DB, et al. 2020. Immunity. 51(3):548-560. PubMed
- Sandborn WJ, et al. 2021. Gastroenterology. 161:1853. PubMed
- JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
- Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
- Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
- Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
- Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
- Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
- Pereira J, et al. 2010. PLoS One. 5:e9277. PubMed
- Dong S, et al. 2021. Nature. 591:117. PubMed
- Wang JC, et al. 2022. Elife. 11:. PubMed
- Yang J, et al. 2020. Nature. 586:572. PubMed
- Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed
- Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
- Melissa M Remy et al. 2017. Cell host & microbe. 22(3):354-365 . PubMed
- Minamitani T, et al. 2015. Proc Natl Acad Sci U S A. 112: 11612-11617. PubMed
- Macdougall CE et al. 2018. Cell metabolism. 27(3):588-601 . PubMed
- Xing Y, et al. 2022. Cancer Lett. 529:100. PubMed
- Webb ER, et al. 2022. iScience. 25:104995. PubMed
- Olson WJ, et al. 2019. Cell Rep. 28:2878. PubMed
- Hilpert C, et al. 2019. J Immunol. 203:3068. PubMed
- Beloor J et al. 2018. Cell host & microbe. 23(4):549-556 . PubMed
- Li Y, et al. 2021. Front Cell Dev Biol. 9:646077. PubMed
- Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
- Giampazolias E, et al. 2021. Cell. . PubMed
- Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
- Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
- Garaycoechea JI, et al. 2018. Nature. 553:171. PubMed
- Srinivasan A, et al. 2021. BMC Immunol. 22:46. PubMed
- Shibad V, et al. 2021. Front Immunol. 12:722451. PubMed
- Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
- Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
- Gorman JA, et al. 2019. Front Immunol. 10:44. PubMed
- Firl DJ et al. 2018. eLife. 7 pii: e33051. PubMed
- He C, et al. 2022. Nat Commun. 13:5459. PubMed
- Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
- Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
- Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed
- Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
- Bennett FC, et al. 2018. Neuron. 98:1170. PubMed
- Liu B, et al. 2013. Development. 140:780. PubMed
- van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed
- Vijay R, et al. 2021. J Exp Med. 218:. PubMed
- Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
- Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
- Hackstein CP, et al. 2022. Nat Commun. 13:7472. PubMed
- Zhang L, et al. 2020. Cell. 442:181. PubMed
- Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
- Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
- Baker GJ, et al. 2020. Cell Syst. 0.647222222. PubMed
- Kunishita Y, et al. 2020. Front Immunol. 11:98. PubMed
- Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
- Vijay R, et al. 2020. Nat Immunol. 21:790. PubMed
- Mincham KT, et al. 2021. Front Immunol. 11:601494. PubMed
- Habener A, et al. 2021. J Allergy Clin Immunol. 147:2281. PubMed
- Nabekura T, et al. 2020. Immunity. 96:52. PubMed
- Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
- Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
- Di Liberto G et al. 2018. Cell. 175(2):458-471 . PubMed
- Stienne C, et al. 2022. Cell Rep. 38:110553. PubMed
- Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
- RRID
- AB_893356 (BioLegend Cat. No. 103235) AB_893354 (BioLegend Cat. No. 103236)